The Covid medications proved ineffective: WHO
16 Oct 2020
A remarkable study from the World Health Organization (WHO) has proved that the four potential medications, now in use and claimed to be effective for Covid-19 treatment have been proved little or no effect on the survival of the Covid patients.
Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon are the four drugs experimented with for the study and research of the World Health Organization (WHO). These drugs were tested randomized among 11266 adult patients in 405 hospitals located in 30 countries across the world. The study carried out 2750 allocations for Remdesivir, 954 for Hydroxychloroquine, 1411 for Lopinavir, 651 for Interferon, and 4088 cases without medicine allocation.
The results of the study have proved that the medications now in use such as Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon have little or no effect on the survival of the Covid patients in terms of overall mortality, initiation of ventilation, and the duration of hospital stay. The study started on 22nd March 2020 and ended up on 4th October 2020. However, the Remdesivir drug manufacturer Gilead rejected the study of the World Health Organization stating that the findings were “inconsistent” and the results have to be reviewed.
Remdesivir was one of the medicines recently used to treat US President Donald Trump when he was in the hospital due to Covid-19. The trials on Hydroxychloroquine and lopinavir/ritonavir were stopped in June 2020 as the trials already proved ineffective.
Currently, the researchers are hopeful on the vaccine expected to come from China which is under development and on trials. The Experts expect this vaccine might be safe to trigger immune responses. However, this vaccine developed by the Beijing Institute of Biological Products has already been approved for an emergency inoculation program in the country.
